RayBiotech

Executive Summary

RayBiotech, founded in 2001 and headquartered in Norcross, GA, is a leading provider of protein analysis tools and diagnostic kits for biomedical research and clinical diagnostics. The company offers a comprehensive suite of products, including antibody arrays, ELISA kits, and multiplex assays, enabling biomarker discovery, validation, and detection. Serving academic, pharmaceutical, and clinical laboratory customers, RayBiotech has established a strong reputation for quality and innovation in the proteomics space. With over 20 years of operational history, the company has built a diverse product portfolio and a global customer base, positioning it as a key player in the growing biomarker and diagnostics market.

Upcoming Catalysts (preview)

• Q3 2026Launch of Next-Generation Multiplex ELISA Platform60% success
• Q1 2027FDA 510(k) Clearance for a Diagnostic Test50% success
• Q4 2026Strategic Partnership with a Major Pharma for Biomarker Services65% success